Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucilla Parnetti

Showing results (81-90 of 283) with videos related to

Pageof 29
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|January 18, 2023
Psychiatric symptoms in multiple sclerosis: a biological perspective on synaptic and network dysfunctionGiulia Menculini, Andrea Mancini, Lorenzo Gaetani, et al.
Expert Opinion on Pharmacotherapy|June 25, 2024
Evaluating bexicaserin for the treatment of developmental epileptic encephalopathiesGiovanni Battista Dell'isola, Alberto Verrotti, Miriam Sciaccaluga, et al.
Neurobiology of Disease|December 24, 2025
Cerebrospinal fluid α-synuclein seed amplification assay positivity is associated with increased plasma neurofilament light chain in Alzheimer's diseaseGiovanni Bellomo, Andrea Toja, Lorenzo Gaetani, et al.
Diagnostics (Basel, Switzerland)|December 1, 2020
A/T/(N) Profile in Cerebrospinal Fluid of Parkinson's Disease with/without Cognitive Impairment and Dementia with Lewy BodiesGiovanni Bellomo, Federico Paolini Paoletti, Elena Chipi, et al.
Nature Reviews. Neurology|February 20, 2013
Cerebrospinal fluid biomarkers in Parkinson diseaseLucilla Parnetti, Anna Castrioto, Davide Chiasserini, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|November 27, 2002
The inflammatory response in cerebral ischemia: focus on cytokines in stroke patientsMaria Grazia De Simoni, Paolo Milia, Michela Barba, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 8, 2017
Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysisPaolo Eusebi, David Giannandrea, Leonardo Biscetti, et al.
Molecular Neurodegeneration|September 9, 2016
No diurnal variation of classical and candidate biomarkers of Alzheimer's disease in CSFClaudia Cicognola, Davide Chiasserini, Paolo Eusebi, et al.
Neurology|August 1, 2022
α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way ForwardGiovanni Bellomo, Chiara Maria Giulia De Luca, Federico Paolini Paoletti, et al.
Clinical Chemistry and Laboratory Medicine|May 6, 2021
Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurementSilvia Paciotti, Erik Stoops, Cindy François, et al.
Pageof 29

Showing results (81-90 of 283) with videos related to

Sort By:
Pageof 29
Journal of Neurology, Neurosurgery, and Psychiatry|January 18, 2023
Psychiatric symptoms in multiple sclerosis: a biological perspective on synaptic and network dysfunctionGiulia Menculini, Andrea Mancini, Lorenzo Gaetani, et al.
Expert Opinion on Pharmacotherapy|June 25, 2024
Evaluating bexicaserin for the treatment of developmental epileptic encephalopathiesGiovanni Battista Dell'isola, Alberto Verrotti, Miriam Sciaccaluga, et al.
Neurobiology of Disease|December 24, 2025
Cerebrospinal fluid α-synuclein seed amplification assay positivity is associated with increased plasma neurofilament light chain in Alzheimer's diseaseGiovanni Bellomo, Andrea Toja, Lorenzo Gaetani, et al.
Diagnostics (Basel, Switzerland)|December 1, 2020
A/T/(N) Profile in Cerebrospinal Fluid of Parkinson's Disease with/without Cognitive Impairment and Dementia with Lewy BodiesGiovanni Bellomo, Federico Paolini Paoletti, Elena Chipi, et al.
Nature Reviews. Neurology|February 20, 2013
Cerebrospinal fluid biomarkers in Parkinson diseaseLucilla Parnetti, Anna Castrioto, Davide Chiasserini, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|November 27, 2002
The inflammatory response in cerebral ischemia: focus on cytokines in stroke patientsMaria Grazia De Simoni, Paolo Milia, Michela Barba, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 8, 2017
Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysisPaolo Eusebi, David Giannandrea, Leonardo Biscetti, et al.
Molecular Neurodegeneration|September 9, 2016
No diurnal variation of classical and candidate biomarkers of Alzheimer's disease in CSFClaudia Cicognola, Davide Chiasserini, Paolo Eusebi, et al.
Neurology|August 1, 2022
α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way ForwardGiovanni Bellomo, Chiara Maria Giulia De Luca, Federico Paolini Paoletti, et al.
Clinical Chemistry and Laboratory Medicine|May 6, 2021
Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurementSilvia Paciotti, Erik Stoops, Cindy François, et al.
Pageof 29